Discussing the FDA Scientific & Regulatory Considerations for Bacteriophage Therapies
Time: 9:10 am
day: Day One
Details:
- Regulatory Considerations for Bacteriophage Therapy
- FDA green lights study of phage-based drug for resistant infections
